Citations

Showing 10 of 108104 citations.

The Perioperative Management of Ascending Aortic Dissection
Gregory, Stephen H. , Yalamuri, Suraj , Bishawi, Muath , Swaminathan, Madhav , Yalamuri, Suraj M

Mayo Clinic

Anesthesia & Analgesia | September 29, 2018 | Volume: 127 | Issue: 6 | Pages: 1302-1313

10.1213/ane.0000000000003747 | PMID 30211773 Get It

Acute aortic syndromes are a distinct group of pathologies involving the wall of the aorta that present acutely and can be potentially fatal unless treated in a timely fashion. The syndrome is dominated by aortic dissections, which comprise ≥95% of all such presentations. Those involving the ascending aorta are particularly lethal and require specific and early surgical treatment compared to dissections involving other parts of the aorta. The surgical repair of an ascending aortic dissection presents multiple challenges to the anesthesiologist. Thoughtful management throughout the perioperative period is critical for minimizing the significant morbidity and mortality associated with this condition. In this narrative review, we provide an overview of the perioperative management of patients presenting for the surgical repair of an ascending aortic dissection. Preoperative discussion focuses on assessment, hemodynamic management, and risk stratification. The intraoperative section includes an overview of anesthetic management, transesophageal echocardiographic assessment, and coagulopathy, as well as surgical considerations that may influence anesthetic management.
Diagnostic Methods for Prosthetic Joint Infection in Korea
Park, Kyung Hwa , Patel, Robin , Patel, Robin

Mayo Clinic

Infection & Chemotherapy | September 29, 2018 | Volume: 50 | Issue: 3 | Pages: 199

10.3947/ic.2018.50.3.199 | PMID 30270579 Get It

Genital Reconstructive Surgery in Females With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Almasri, Jehad , Zaiem, Feras, Rodríguez‐Gutiérrez, René , Tamhane, Shrikant , Iqbal, Anoop Mohamed, Speiser, Phyllis , Baskin, Laurence S. , Murad, M. Hassan , Tamhane, Shrikant U, Murad, M Hassan , Prokop, Larry J. , Bancos, Irina

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | September 29, 2018 | Volume: 103 | Issue: 11 | Pages: 4089-4096

10.1210/jc.2018-01863 | PMID 30272250 Get It

Abstract Background Females with congenital adrenal hyperplasia (CAH) and atypical genitalia often undergo complex surgeries; however, their outcomes remain largely uncertain. Methods We searched several databases through 8 March 2016 for studies evaluating genital reconstructive surgery in females with CAH. Reviewers working independently and in duplicate selected and appraised the studies. Results We included 29 observational studies (1178 patients, mean age at surgery, 2.7 ± 4.7 years; mostly classic CAH). After an average follow-up of 10.3 years, most patients who had undergone surgery had a female gender identity (88.7%) and were heterosexual (76.2%). Females who underwent surgery reported a sexual function score of 25.13 using the Female Sexual Function Index (maximum score, 36). Many patients continued to complain of substantial impairment of sensitivity in the clitoris, vaginal penetration difficulties, and low intercourse frequency. Most patients were sexually active, although only 48% reported comfortable intercourse. Most patients (79.4%) and treating health care professionals (71.8%) were satisfied with the surgical outcomes. Vaginal stenosis was common (27%), and other surgical complications, such as fistulas, urinary incontinence, and urinary tract infections, were less common. Data on quality of life were sparse and inconclusive. Conclusion The long-term follow-up of females with CAH who had undergone urogenital reconstructive surgery shows variable sexual function. Most patients were sexually active and satisfied with the surgical outcomes; however, some patients still complained of impairment in sexual experience and satisfaction. The certainty in the available evidence is very low.
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
Speiser, Phyllis , Arlt, Wiebke , Auchus, Richard J. , Baskin, Laurence S. , Conway, Gerard S. , Merke, Deborah P. , Meyer‐Bahlburg, Heino F. L. , Miller, Walter L. , Murad, M. Hassan , White, Perrin C. , Murad, M Hassan , Arlt, Wiebke , Merke, Deborah P , Oberfield, Sharon E.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | September 28, 2018 | Volume: 103 | Issue: 11 | Pages: 4043-4088

10.1210/jc.2018-01865 | PMID 30272171 Get It

Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Tamhane, Shrikant , Rodríguez‐Gutiérrez, René , Iqbal, Anoop Mohamed, Speiser, Phyllis , Murad, M. Hassan , Murad, Mohammad Hassan, Murad, M Hassan , Prokop, Larry J. , Bancos, Irina

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | September 28, 2018 | Volume: 103 | Issue: 11 | Pages: 4097-4103

10.1210/jc.2018-01862 | PMID 30272185 Get It

Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid Prescribing
Razouki, Zayd, Khokhar, Bushra, Philpot, Lindsey M. , Ebbert, Jon O. , Philpot, Lindsey M

Mayo Clinic

Pain Medicine | September 28, 2018 | Volume: 20 | Issue: 10 | Pages: 1934-1941

10.1093/pm/pny204 | PMID 30403814 Get It

Abstract Background Many clinicians who prescribe opioids for chronic noncancer pain (CNCP) express concerns about opioid misuse, addiction, and physiological dependence. We evaluated the association between the degree of clinician concerns (highly vs less concerned), clinician attributes, other attitudes and beliefs, and opioid prescribing practices. Methods A web-based survey of clinicians at a multispecialty medical practice. Results Compared with less concerned clinicians, clinicians highly concerned with opioid misuse, addiction, and physiological dependence were more confident prescribing opioids (risk ratio [RR] = 1.34, 95% confidence interval [CI] = 1.08–1.67) but were more reluctant to do so (RR = 1.13, 95% CI = 1.03–1.25). They were more likely to report screening patients for substance use disorder (RR = 1.18, 95% CI = 1.01–1.37) and to discontinue prescribing opioids to a patient due to aberrant opioid use behaviors (RR = 1.30, 95% CI = 1.13–1.50). They were also less likely to prescribe benzodiazepines and opioids concurrently (RR = 0.40, 95% CI = 0.25–0.65). Highly concerned clinicians were more likely to work in clinics which engage in “best practices” for opioid prescribing requiring urine drug screening (RR = 4.65, 95% CI = 2.51–8.61), prescription monitoring program review (RR = 2.90, 95% CI = 1.84–4.56), controlled substance agreements (RR = 4.88, 95% CI = 2.64–9.03), and other practices. Controlling for clinician concern, prescribing practices were also associated with clinician confidence, reluctance, and satisfaction. Conclusions Highly concerned clinicians are more confident but more reluctant to prescribe opioids. Controlling for clinician concern, confidence in care and reluctance to prescribe opioids were associated with more conservative prescribing practices.
Till Death Do Us Part
Jannetto, Paul J. , Langman, Loralie J., Bornhorst, Joshua A. , Bornhorst, Joshua, Bornhorst, Joshua

Mayo Clinic

Clinical Chemistry | September 28, 2018 | Volume: 64 | Issue: 10 | Pages: 1548-1549

10.1373/clinchem.2018.292193 | PMID 30266721 Get It

Methylation-dependent Tissue Factor Suppression Contributes to the Reduced Malignancy of IDH1-mutant Gliomas
Unruh, Dusten , Mirkov, Snezana, Wray, Brian, Drumm, Michael , Lamano, Jonathan B., Li, Yuping D., Haider, Qazi F., Javier, Rodrigo, McCortney, Kathleen , Saratsis, Amanda , James, C. David , McCortney, Kathleen , Haider, Qazi F., Scholtens, Denise M. , Sarkaria, Jann N. , Horbinski, Craig

Mayo Clinic

Clinical Cancer Research | September 28, 2018 | Volume: 25 | Issue: 2 | Pages: 747-759

10.1158/1078-0432.ccr-18-1222 | PMID 30266764 Get It

Abstract Purpose: Gliomas with isocitrate dehydrogenase 1 mutations (IDH1mut) are less aggressive than IDH1 wild-type (IDH1wt) gliomas and have global genomic hypermethylation. Yet it is unclear how specific hypermethylation events contribute to the IDH1mut phenotype. Previously, we showed that the gene encoding the procoagulant tissue factor (TF), F3, is among the most hypermethylated and downregulated genes in IDH1mut gliomas, correlating with greatly reduced thrombosis in patients with IDH1mut glioma. Because TF also increases the aggressiveness of many cancers, the current study explored the contribution of TF suppression to the reduced malignancy of IDH1mut gliomas. Experimental Design: TF expression was manipulated in patient-derived IDH1mut and IDH1wt glioma cells, followed by evaluation of in vitro and in vivo behavior and analyses of cell signaling pathways. Results: A demethylating agent, decitabine, increased F3 transcription and TF-dependent coagulative activity in IDH1mut cells, but not in IDH1wt cells. TF induction enhanced the proliferation, invasion, and colony formation of IDH1mut cells, and increased the intracranial engraftment of IDH1mut GBM164 from 0% to 100% (P = 0.0001). Conversely, TF knockdown doubled the median survival of mice engrafted with IDH1wt/EGFRvIIIamp GBM6, and caused complete regression of IDH1wt/EGFRamp GBM12 (P = 0.001). In vitro and in vivo effects were linked to activation of receptor tyrosine kinases (RTK) by TF through a Src-dependent intracellular pathway, even when extracellular RTK stimulation was blocked. TF stimulated invasion predominately through upregulation of β-catenin. Conclusions: These data show that TF suppression is a component of IDH1mut glioma behavior, and that it may therefore be an attractive target against IDH1wt gliomas.
Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
Vemuri, Prashanthi , Lesnick, Timothy G. , Przybelski, Scott A. , Graff‐Radford, Jonathan, Reid, Robert I. , Lowe, Val J. , Zuk, Samantha M., Senjem, Matthew L. , Schwarz, Christopher G. , Gunter, Jeffrey L. , Kantarci, Kejal , Mielke, Michelle M. , Petersen, Ronald C. , Jack, Clifford R. , Jack, Clifford R , Schwarz, Christopher G , Mielke, Michelle M , Reid, Robert I , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal , Graff‐Radford, Jonathan , Machulda, Mary M. , Knopman, David S.

Mayo Clinic

Annals of Neurology | September 28, 2018 | Volume: 84 | Issue: 5 | Pages: 705-716

10.1002/ana.25346 | PMID 30264411 Get It

ObjectiveRecent availability of amyloid and tau positron emission tomography (PET) has provided us with a unique opportunity to measure the association of systemic vascular health with brain health after accounting for the impact of Alzheimer disease (AD) pathologies. We wanted to quantify early cerebrovascular health–related magnetic resonance imaging brain measures (structure, perfusion, microstructural integrity) and evaluate their utility as a biomarker for cerebrovascular health.MethodsWe used 2 independent samples (discovery, n = 390; validation, n = 1,035) of individuals, aged ≥ 60 years, along the cognitive continuum with imaging from the population‐based sample of Mayo Clinic Study of Aging. We ascertained vascular health by summing up recently existing cardiovascular and metabolic conditions (CMC) from health care records (hypertension, hyperlipidemia, cardiac arrhythmias, coronary artery disease, congestive heart failure, diabetes mellitus, and stroke). Using multiple regression models, we quantified associations between CMC and brain health after accounting for age, sex, education/occupation, and AD burden (from amyloid and tau PET).ResultsSystemic vascular health was associated with medial temporal lobe thinning, widespread cerebral hypoperfusion, and loss of microstructural integrity in several white matter tracts including the corpus callosum and fornix. Further investigations suggested that microstructural integrity of the genu of the corpus callosum was suitable for assessing prodromal cerebrovascular health, had similar distributions in the discovery and independent validation datasets, and predicted cognitive performance above and beyond amyloid deposition.InterpretationSystemic vascular health has significant impact on brain structure and function. Quantifying prodromal cerebrovascular health–related brain measures that are independent of AD pathology–related changes has great utility for cognitive aging. Ann Neurol 2018;84:713–724
Preliminary Findings From the First Pilot Phase of the Collaborative Innovation and Improvement Network
Sisaithong, Kristen, Carrico, Robert J., Reddy, Kunam S.

Mayo Clinic

Transplantation | September 28, 2018 | Volume: 102 | Issue: 10 | Pages: 1590-1592

10.1097/tp.0000000000002347 | PMID 30247439 Get It